Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations?
- 4 August 2018
- journal article
- research article
- Published by Springer Nature in World Journal of Urology
- Vol. 37 (4) , 691-699
Abstract
To investigate, if and how omitting gadolinium-based contrast agents (GBCA) and dynamic contrast-enhanced imaging (DCE) influences diagnostic accuracy and tumor detection rates of prostate MRI.Keywords
This publication has 31 references indexed in Scilit:
- Validation of the Dominant Sequence Paradigm and Role of Dynamic Contrast-enhanced Imaging in PI-RADS Version 2Radiology, 2017
- Performance of PI-RADS version 1 versus version 2 regarding the relation with histopathological resultsWorld Journal of Urology, 2016
- PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2European Urology, 2016
- Prostate MRI: Can we do without DCE sequences in 2013?Diagnostic and Interventional Imaging, 2013
- ESUR prostate MR guidelines 2012European Radiology, 2012
- Value of Diffusion-Weighted Imaging for the Prediction of Prostate Cancer Location at 3T Using a Phased-Array CoilInvestigative Radiology, 2007
- Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: Correlation with stepwise histopathologyJournal of Magnetic Resonance Imaging, 2007
- Prostate cancer screening: The clinical value of diffusion‐weighted imaging and dynamic MR imaging in combination with T2‐weighted imagingJournal of Magnetic Resonance Imaging, 2006
- Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable?European Radiology, 2006
- Prostate Cancer Localization with Dynamic Contrast-enhanced MR Imaging and Proton MR Spectroscopic ImagingRadiology, 2006